Loading...

ANIP ANI PHARMACEUTICALS INC Management Changes 8-K Filing

N PH

NP

ANI PHARMACEUTICALS INC

(ANIP)

2026 8-K

Stockholder Meeting Update

Investor Update

Q1 Financial Results

Audit Firm Changes

Investor Presentation Update

Quarterly Results

Financial Results Update

Board Transition Update

Investor Presentation Update

Financial Results

Preferred Shares Conversion

Investor Conference Update

Financial Statements

NEW DAY Study Results

Financial Statements

Investor Meetings

Investor Meetings

Financial Statements

Rights Offerings

Royalty Buy-Out

Investor Presentation

Financial Results

Investor Presentation

Financial Results

Investor Presentation

Financial Results

Earnings Report

Acquisition Completed

Private Offering

Financial Results Announcement

Merger Agreement

Results of Operations and F...

Departure of Directors or C...

Panel Discussion at Biotech...

Financial Results Announcement

Investor Meeting

Investor Presentation

Financial Results Announcement

Agreement for Sale of Manuf...

Presentation at Conference

Investor Presentation

Presentation at Conference

Financial Results Announcement

Presentation at Conference

Presentation to Investors

Presentation to Investors

Appointment of Director

Financial Results Announcement

Investor Presentation

Annual Meeting Approval

Sale of Common Stock

Public Offering

Underwritten Equity Offering

Policy Amendment and Direct...

Earnings Reports

FDIC Control of SVB

Earnings Reports

Bylaws Amendments

External Links:

ANI Pharmaceuticals, Inc. dismissed EisnerAmper LLP as its independent auditor on April 1, 2026, and appointed Ernst & Young LLP to replace them, also effective April 1, 2026. There were no issues reported with EisnerAmper's audits for previous years, indicating a smooth transition.

AI Assistant

ANI PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.